What kind of clinical, epidemiological, and biological data is essential for the diagnosis of Lyme borreliosis? Dermatological and ophtalmological courses of Lyme borreliosis;Sur quels éléments cliniques, épidémiologiques et biologiques faut-il évoquer la maladie de Lyme ? Aspects dermatologiques et ophtalmologiques au cours de la maladie de Lyme

Medecine et Maladies Infectieuses

Volumn 37, Issue SUPPL. 3, 2007, Pages

  Boye T ^a  

^a Hopital d'Instruction des Armees Legouest   (France)

Author keywords

Borrelia burgdorferi; Lyme disease; Tick borne diseases

Indexed keywords

ACRODERMATITIS; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; DISEASE COURSE; ERYTHEMA CHRONICUM MIGRANS; HISTOPATHOLOGY; HUMAN; LABORATORY DIAGNOSIS; LYME DISEASE; NEUROLOGIC DISEASE; PSEUDOLYMPHOMA; SEROLOGY; SYMPTOMATOLOGY; T LYMPHOCYTE; TICK BITE; BACTERIAL EYE INFECTION; BACTERIAL SKIN DISEASE; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; MICROBIOLOGY;

EYE INFECTIONS, BACTERIAL; HUMANS; LYME DISEASE; SKIN DISEASES, BACTERIAL;

EID: 36849069920     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2007.10.002     Document Type: Article

References (187)

1. Afzelius A. Verhandlungen der dermatologischen Gesellshaft zu Stockholm (sitzung vom 16 dezember 1909). Arch. Dermatol. Syph. 101 (1910) 405-406
2. Steere A.C., Malawista S.E., Hardin J.A., Ruddy S., Askenase W., and Andiman W.A. Erythema chronicum migrans and Lyme arthritis. Ann. Intern. Med. 86 (1977) 685-698
3. Burgdorfer W., Barbour A.G., Hayes S.F., Benach J., Grunwaldt E., and Davis J.P. Lyme disease-a tick borne spirochetosis?. Science 216 (1982) 1317-1319
4. Grubhoffer L., Golovchenko M., Vancova M., Zacharovova-Slavickova K., Rudenko N., and Oliver Jr. J.H. Lyme borreliosis: insights into tick-/host-Borrelia relations. Folia Parasitol. (Praha) 52 4 (2005) 279-294
5. Stanek G., and Strle F. Lyme borreliosis. Lancet 362 (2003) 1639-1647
6. Wang G., van Dam A.P., Schwartz I., and Dankert J. Molecular typing of Borrelia burgdorferi sensu lato: taxonomic, epidemiological, and clinical implications. Clin. Microbiol. Rev. 12 (1999) 633-653
7. Collares-Pereira M., Couceiro S., Franca I., Kurtenbach Schäfer S.M., Vitorino L., et al. First isolation of Borrelia lusitaniae from a patient. J. Clin. Microbiol. 42 (2004) 1316-1318
8. Lipsker D., Hansmann Y., Limbach F., Clerc C., Tranchant C., Grunenberger F., et al. Disease expression of Lyme borreliosis in northeastern France. Eur. J. Clin. Microbiol. Infect. Dis 20 4 (2001) 225-230
9. Van Dam A.P., Kuiper H., Vos K., Widjokusumo A., Dejongh B.M., Spanjaard L., et al. Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis. Clin. Infect. Dis. 17 (1993) 708-717
10. Balmelli T., and Piffaretti J.C. Association between different clinical manifestations of Lyme disease and different species of Borrelia burgdorferi sensu lato. Res. Microbiol. 146 4 (1995) 329-340
11. Strle F., Nadelman R.B., Cimperman J., Nowakowski J., Picken R.N., Schwartz I., et al. Comparison of culture-confirmed erythema migrans caused by Borrelia burgdorferi sensu stricto in New York State and by Borrelia afzelii in Slovenia. Ann. Intern. Med. 130 (1999) 32-36
12. Rahn D.W., and Malawista S.E. Lyme disease: recommandations for diagnosis and treatment. Ann. Intern. Med. 114 (1991) 472-481
13. Malane M.S., Grant-Kels J.M., Feder H., and Luger S. Diagnosis of Lyme disease based on dermatologic manifestations. Ann. Intern. Med. 114 (1991) 490-498
14. Wormser G.P., Nadelman R.B., Dattwyler R., Dennis D.T., Shapiro E.D., Steere A.C., et al. Practice guidelines for the treatment of Lyme disease. Clin. Infect. Dis 31 Suppl1 (2000) S1-S4
15. Aguero-Rosenfeld M.E., Wang G., Schwartz I., and Wormser G.P. Diagnosis of Lyme Borreliosis Clin. Microbiol. Rev. 18 (2005) 484-509
16. Cameron D., Gaito A., Harris N., Bach G., Bellovin S., Bock K., et al. Evidence-based guidelines for the management of Lyme disease. Expert Rev. Anti Infect. Ther. 2 Suppl (2004) S1-S13
17. Stanek G., O'Connell S., Cimmino M., Aberer E., Kristoferitsch W., Granström M., et al. European union concerted action on risk assessment in Lyme borreliosis: clinical case definitions for Lyme borreliosis. Wien. Klin. Wochenschr. 108 (1996) 741-747
18. Wilske B, Zöller L, Brade V, Eiffert H, Göbel UB. Stanek G qualitätstandads in der mikrobiologisch infektiologishen diagnostik http://pollux.mpk.med.uni-muenchen.de/alpha1/nrz-borrelia/miq-lyme/index.html: Urban and fischer, 2000.
19. Brouqui P., Bacellar F., Baranton G., Birtles R.J., Bjoersdorff A., Blanco J.R., et al. Guidelines for the diagnosis of tick-borne bacterial diseases in Europe. Clin. Microbiol. Infect. 10 12 (2004) 1108-1132
20. Cimmino M.A. Relative frequency of Lyme borreliosis and of its clinical manifestations in Europe. European community concerted action on risk assessment in Lyme borreliosis. Infection 26 (1998) 298-300
21. Berglund J., Eitrem R., Onstein K., Lindberg A., Ringer A., Elmrud H., et al. An epidemiologic study of Lyme disease in southern Sweden. N. Engl. J. Med 333 (1995) 1319-1327
22. George J.C., and Chastel C. Tick-borne diseases and ecosystem modifications in Lorraine. Bull. Soc. Pathol. Exot. 95 2 (2002) 95-99
23. Vos K., Van Dam A.P., Kuiper H., Bruins H., Spanjaard L., and Dankert J. Seroconversion for lyme borreliosis among dutch military. Scand. J. Infect. Dis. 26 (1994) 427-434
24. Christiann F., Rayet P., Patey O., and Lafaix C. Epidemiology of Lyme disease in France: Lyme borreliosis in the region of Berry sud: a six year retrospective. Eur. J. Epidemiol. 12 5 (1996) 479-483
25. Rath P.M., Ibershoff B., Mohnhaupt A., Albig J., Eljaschewitsch B., Jurgen D., et al. Seroprevalence of Lyme borreliosis in forestry workers from Brandeburg. Germany Eur. J. Clin. Microbiol. Infect. Dis. 15 (1996) 372-377
26. Arteaga F., Gotlightly M.G., Garcia Perez A., Barral M., Anda P., and Garcia-Monco J.C. Disparity between serological reactivity to Borrelia burgdorferi and evidence of past disease in a high -risk group. Clin. Infect. Dis. 27 (1998) 1210-1213
27. Nubling M., Rieger M.A., Batsford S., Wagner M., Wertenschlag E., and Hofmann F. Seroprevalence of infection with Borrelia burgdorferi sensu lato. l. in two adjacent regions of eastern France and southwestern Germany. Int. J. Med. Microbiol. 291 Suppl 33 (2002) 218
28. Nahimana I., Gern L., Blanc D.S., Praz G., Francioli P., and Peter O. Risk of Borrelia burgdorferi infection in western Switzerland following a tick bite. Eur. J. Clin. Microbiol. Infect. Dis. 23 (2004) 603-608
29. Fahrer H., Sauvain M.J., Zhioua E., Van Hoecke C., and Gern L.E. Longterm survey (7 years) in a population at risk for Lyme borreliosis: what happens to the seropositive individuals?. Eur. J. Epidemiol. 14 2 (1998) 117-123
30. Nadal D., Wunderli W., Briner H., and Hansen K. Prevalence of antibodies to Borrelia burgdorferi in forestry workers and blood donors from the same region in Switzerland. Eur. J. Clin. Microbiol. Infect. Dis. 8 (1989) 992-995
31. Asbrink E., and Hovmark A. Early and late cutaneous manifestations in Ixodes-borne borreliosis (erythema migrans borreliosis, Lyme borreliosis). Ann. N. Y. Acad. Sci. 539 (1988) 4-15
32. Duray P.H., and Steere A.C. Clinical pathologic correlations of Lyme disease by stage. Ann. N. Y. Acad. Sci. 539 (1988) 65-79
33. Müllegger R. Dermatological manifestations of Lyme borreliosis. Eur. J. Dermatol. 14 (2004) 296-309
34. Lipschütz B. Uber eine seltene Erythemform (erythema chronicum migrans). Arch. Dermatol. Syph. 118 (1913) 349-356
35. Christova I., and Komitova R. Clinical and epidemiological features of Lyme borreliosis in Bulgaria. Wien Klin. Wochenschr 116 (2004) 42-46
36. Ornstein K., Berglund J., Nilsson I., Norrby R., and Bergstrom S. Characterization of Lyme borreliosis isolates from patients with erythema migrans and neuroborreliosis in southern Sweden. J. Clin. Microbiol. 39 4 (2001) 1294-1298
37. Wienecke R., Zöling N., Neubert U., Schlüpen E.M., Meurer M., and Volkenandt M. Molecular Subtyping of Borrelia burgdorferi in erythema Migrans and Acrodermatitis Chronica Atrophicans. J. Invest. Dermatol. 103 (1994) 19-22
38. Ruzic-Sabljic E., Strle F., Cimperman J., Maraspin M.V., Lotric-Furlan S., and Strle F. Characterisation of Borrelia burgdorferi sensu lato strains isolated from patients with skin manifestations of Lyme borreliosis residing in Slovenia. J. Med. Microbiol. 49 (2000) 47-53
39. Strle F., Nelson J.A., and Ruzic-Sabljic E. Cimperman European Lyme borreliosis: 231 culture-confirmed cases involving patients with erythema migrans. Clin. Infect. Dis. 23 (1996) 61-65
40. Nadelman R.B., and Wormser G.P. Lyme borreliosis. Lancet 352 (1998) 557-565
41. Kuiper H., Cairo I., Van Dam A., De Jongh B., Ramselaar T., Spanjaard L., et al. Solitary erythema migrans: a clinical, laboratory and epidemiological study of 77 Dutch patients. Br. J. dermatol. 130 (1994) 466-472
42. Rijpkema S.G., Tazelaard D., Molkenboer M., Noordhoek G., Plantinga G., Schouls L., et al. Detection of Borrelia afzelii, Borrelia burgdorferi sensu stricto, Borrelia Garinii and group VS116 by PCR in skin biopsies of patients with erythema migrans and acrodermatitis chronica atrophicans. Clin. Microbiol. Infect. 3 (1997) 109-116
43. Antoni-Bach N., Jaulhac B., Hansmann Y., Limbach F., and Lipsker D. Espèces de Borrelia responsables d'érythème migrant en Alsace. Ann. Dermatol. Venereol. 129 (2002) 15-18
44. Hunfeld K.P., Ruzic-Sabljic E., Norris D.E., Kraiczy P., and Strle F. In vitro susceptibility testing of Borrelia burgdorferi sensu lato isolates cultured from patients with erythema migrans before and after antimicrobial chemotherapy. Antimicrob. Agents Chemother. 49 4 (2005) 1294-1301
45. Smith R.P., Schoen R.T., Rahn D.W., Sikand V.K., Nowakowski J., Parenti D.L., et al. Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans. Ann. Intern. Med. 136 6 (2002) 421-428
46. Asbrink E., and Olson I. Clinical manifestations of erythema chronicum migrans Afzelius in 161 patients: a comparison with Lyme disease. Acta Derm. Venereol. 65 (1985) 43-52
47. Asbrink E., Olsson I., and Hovmark A. Erythema chronicum migrans Afzelius in Sweden: a study on 231 patients. bl. Bakt Hyg. A. 263 (1986) 229-236
48. Strle F., Videcnik J., Zorman P., Cimperman J., Lotric-Furlan S., and Maraspin V. Clinical and epidemiological findings for patients with erythema migrans. Comparaison of cohorts from the years 1993 and 2000. Wien. Klin. Wochenschr. 114 (2002) 493-497
49. Berger B.W., Johson R.C., Kodner C., and Coleman L. Cultivation of Borrelia burgdorferi from the blood of two patients with erythema migrans lesions lacking extracutaneous signs and symptoms of Lyme disease. J. Am. Acad. Dermatol. 30 (1994) 48-51
50. Stanek G., Breier F., Menziger G., Schaar B., Hafner M., and Parsch H. Erythema migrans and serodiagnosis by enzyme immunoassay and immunoblot with three Borrelia species. Wien. Klin. Wochenschr. 111 (1999) 951-956
51. Plorer A., Sepp N., Schmutzhard E., Krabichler S., Trobos S., Schauer G., et al. Effects of adequate versus inadequate treatment of cutaneous manifestations of Lyme borreliosis on the incidence of late complications and late serologic status. J. Invest. Dermatol. 100 2 (1993) 103-109
52. Goodman J.L., Bradley J.F., Ross A.E., Goelner P., Lagus A., Vitale B., et al. Bloodstream invasion in early Lyme disease: results from a prospective, controlled, blinded study using the polymerase chain reaction. Am. J. Med. 99 (1995) 6-12
53. Aguero-Rosenfeld M.E., Nowakowski J., Bittker S., Cooper D., Nadelman R.B., and Wormser G.P. Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. Clin. Microbiol. 34 (1996) 1-9
54. Nadelman R.B., Nowakowski J., Forseter G., Goldberg N.S., Bittker S., Cooper D., et al. The clinical spectrum of early Lyme borreliosis in patients with culture -confirmed erythema migrans. Am. J. Med. 100 (1996) 502-508
55. Hulshof M.M., Vandenbroucke J.P., Nolmans L.M.K.E., Spanjaard L., Bavinck J.N.B., and Dijkmans B.A.C. Long-term prognosis of patients treated for erythema chronicum migrans and acrodermatitis chronica atrophicans. Arch. Dermatol. 133 (1997) 33-37
56. Logar M., Lotric-Furlan S., Maraspin V., Cimperman J., Jurca T., Ruzic-Sabljic E., et al. Has the presence or absence of Borrelia burgdorferi sensu lato as detected by skin culture any influence on the course of erythema migrans?. Wien Klin Wochenschr 111 (1999) 945-950
57. Dumler J.S. Molecular diagnosis of Lyme disease: review and meta-analysis. Mol. Diagn. 6 1 (2001) 1-11
58. Berger B.W., Clemmensen O.J., and Avkerman A.B. Lyme disease is a spirochetosis. Am J Dermathopathol 5 (1983) 111-124
59. Berger B.W., Johnson R.C., Kodner C., and Coleman L. Cultivation of Borrelia burgdorferi from erythema migrans lesions and perilesional skin. J. Clin. Microbiol. 30 (1992) 359-361
60. Jurca T., Ruzic-Sabljic E., Lotric-Furlan S., Maraspin V., Cimperman J., Picken R.N., et al. Comparison of peripheral and central biopsy sites for the isolation of Borrelia burgdorferi sensu lato from erythema migrans skin lesions. Clin. Infect. Dis 27 3 (1998) 636-638
61. Maraspin V., Cimpermann J., Lotric-Furlan S., Logar M., Ruzic-Sabljic, and Strle F. Erythema migrans in solid-organ transplant recipients. Clin. Infect. Dis. 42 (2006) 1751-1754
62. Maraspin V., Cimpermann J., Lotric-Furlan S., Pleterski-Rigler D., and Strle F. Erythema migrans in pregnancy. Wien. Klin. Wochenschr. 111 (1999) 22-23
63. Strle F., Maraspin V., Lotric-Furlan S., Ruzic-Sabljic E., and Cimperman J. Azithromycin and doxycycline for treatment of Borrelia culture-positive erythema migrans. Infection 24 (1996) 64-68
64. Arnez M., Pleterski-Rigler D., Luznik-Bufon T., Ruzic-Sabljic E., and Strle F. Solitary erythema migrans in children: comparison of treatment with azithromycin and phenoxymethylpenicillin. Wien Klin Wochenschr 114 13-14 (2002) 498-504
65. Breier F., Kuntz G., Klade H., Stanek G., and Aberer E. Erythema migrans: three week treatment for prevention of late Lyme borreliosis. Infection 24 (1996) 69-72
66. Weber K. Treatment failure in Erythema migrans: a review. Infection 24 (1994) 73-77
67. Hunfeld K.P., Ruzic-Sabljic E., Norris D.E., Kraiczy P., and Strle F. In vitro susceptibility testing of Borrelia burgdorferi sensu lato isolates cultured from patients with erythema migrans before and after antimicrobial chemotherapy. Antimicrob. Agents Chemother. 49 4 (2005) 1294-1301
68. Lipsker D., Antoni-Bach N., Hansmann Y., and Jauhlac B. Long-term prognosis of patients treated for erythema migrans in France. Br. J. dermatol. 146 (2002) 872-876
69. Maraspin V., Cimperman J., Lotric-Furlan S., Ruzic-Sabljic E., Jurca T., and Strle F. Cerebrospinal fluid findings in adult patients with multiple erythema migrans. Wien. Klin. Wochenschr. 114 (2002) 505-509
70. Arnez M., Pleterski-Rigler D., Luznik-Bufon, Ruzic-Sabljic E., and Strle F. Children with multiple erythema migrans: are there any pretreatment symptoms and/or sign suggestive for central nervous system involvement?. Wien. Klin. Wochenschr. 114 (2002) 524-529
71. Hovmark A., Asbrink E., and Olsson L. The spirochetal etiology of lymphadenosis benigna cutis solitaria. Acta Derm. Venereol. 66 (1986) 479-484
72. Albrecht S., Hofstadter S., Artob H., Chaban O., and From L. Lymphadenosis benigna cuti resulting from Borrelia infection. J. Am. Acad. Dermatol. 24 (1991) 621
73. Maraspin V., Cimperman J., Lotric-Furlan S., Ruzic-Sabljic E., Jurca T., Picken R., et al. Solitary Borrelial lymphocytoma in adult patients. Wien. Klin. Wochenschr. 114 (2002) 515-523
74. Strle F., Pleterski-Rigler D., Stanek G., Pejovnik-Pustinek A., Ruzic A., and Cimperman J. Solitary Borrelial lymphocytoma: report of 36 cases. Infection 20 4 (1992) 201-206
75. Colli C., Leinweber B., Mülleger R., Chott A., Kerl H., and Cerroni L. Borrelia burgdorferi-associated lymphocytoma cutis: clinicopathologic, immunophenotypic, and molecular study of 106 cases. J. Cutan. Pathol. 31 (2004) 232-240
76. Picken R., Strle F., Ruzic-Sabljic E., Maraspin V., Lotric-Furlan S., Cimperman J., et al. Molecular subtyping of Borrelia burgdorferi sensu lato: isolates from five patients with solitary lymphocytoma. J. Invest. Dermatol. 108 (1997) 92-97
77. Ruzic-Sabljic E., Strle F., Cimperman J.M., Maraspin V., Lotric-Furlan S., and Strle F. Characterisation of Borrelia burgdorferi sensu lato strains isolated from patients with skin manifestations of Lyme borreliosis residing in Slovenia. J. Med. Microbiol. 49 (2000) 47-53
78. Ruzic-Sabljic E., Maraspin V., Lotric-Furlan S., Jurca T., Logar M., Pikelj A., et al. Characterization of Borrelia burgdorferi sensu lato strains isolated from human material in Slovenia. Wien klin Wochenschr 114 (2002) 544-550
79. Busch U., Hizo-Teufel C., Bohmer R., Fingerle V., Rossler D., Wilske B., et al. Borrelia burgdorferi sensu lato strains isolated from cutaneous Lyme borreliosis biopsies differentiated by pulsed-field gel electrophoresis. Scand. J. Infect. Dis. 28 6 (1996) 583-589
80. Strle F., Maraspin V., Pleterski-Rigler D., Lotric-Furlan S., Ruzic-Sabljic E., Jurca T., et al. Treatment of Borrelial Lymphocytoma. Infec. 24 1 (1996) 80-84
81. Cerroni L., Zochling N., Putz B., and Kerl H. Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma. J. Cutan. Pathol. 24 8 (1997) 457-461
82. Grange F., Wechsler J., Guillaume J.C., Tortel J., Tortel M.C., Audhuy B., et al. Borrelia burgdorferi-associated lymphocytoma cutis simulating a primary cutaneous large B-cell lymphoma. J. Am. Acad. Dermatol. 47 (2002) 530-534
83. Goodlad J.R., Davidson M.M., Hollowood K., Ling C., MacKenzie C., Christie I., et al. Primary cutaneous B-cell lymphoma and Borrelia burgdorferi infection in patients from the Highlands of Scotland. Am. J. Surg. Pathol. 24 9 (2000) 1279-1285
84. Herxheimer K., and Hartmann K. Ueber Acrodermatitis chronica atrophicans. Arch. Dermatol. Syph. 61 (1902) 57-76
85. Nygard K., Brantsaeter A.B., and Mehl R. Disseminated and chronic Lyme borreliosis in Norway, 1995-2004. Euro. Surveill. 10 (2005) 235-238
86. Asbrink E., Brehmer, Anderson E., and Hovmark A. Acrodermatitis chronica atrophicans a spirochetosis. Clinical and histopahological picture based on 32 patients; course and relationship to erythema chronicum migrans Afzelius. Am. J. Dermatopathol. 8 (1986) 209-219
87. Asbrink E. Erythema chronicum migrans Afzelius and acrodermatitis chronica atrophicans. Early and late manifestations of ixodes ricinus borne Borrelia spirochetes. Acta Derm. Venereol. suppl118 (1985) 1-63
88. Brehmer-Andersson E., Hovmark A., and Asbrink E. Acrodermatitis chronica atrophicans: histopathologic findings and clinical correlations in 111 cases. Acta Derm. Venereol. 78 3 (1998) 207-213
89. Brzonova I., Wollenberg A., and Prinz J.C. Acrodermatitis chronica atrophicans affecting all four limbs in an 11-year-old girl. Br. J. Dermatol. 147 2 (2002) 375-378
90. Zalaudek I., Leinweber B., Kerl H., and Müllegger R. Acrodermatis chronica atrophicans in 15-year-old girl misdiagnosed as venous insufficiency for 6 years. J. Am. Acad. Dermatol. 52 (2005) 1091-1094
91. Muellegger R., Shlüpen E.M., Millner M.M., Soyer H.P., Volkennandt M., and Kerl H. Acrodermatis chronica atrophicans in an 11-year-old girl. Br. J. Dermatol. 135 (1996) 609-612
92. Ohlenbusch A., Matuschka F.R., Richter D., Christen H.J., Thomssen R., Spielman A., et al. Etiology of the acrodermatitis chronica atrophicans lesion in Lyme disease. J. Infect. Dis. 174 (1996) 421-423
93. Picken R.N., Strle F., Picken M.M., Ruzic-Sabljic E., Maraspin V., Lotric-Furlan S., et al. Identification of three species of Borrelia burgdorferi sensu lato (Borrelia.burgdorferi sensu stricto, Borrelia garinii, and Borrelia afzelii) among isolates from acrodermatitis chronica atrophicans lesions. J. Invest. Dermatol. 110 3 (1998) 211-214
94. Maraspin V., Ruzic-Sabljic E., and Strle F. Isolation of Borrelia burgdorferi sensu lato from a fibrous nodule in a patient with acrodermatitis chronica atrophicans. Wien. Klin. Wochenschr. 114 (2002) 533-534
95. Cribier B., and Lipsker D. Borréliose de Lyme : revue générale. Nouv. Dermatol. 12 (1993) 622-638
96. Aberer E., Breier F., Stanek G., and Schmidt B. Success and failure in the treatment of acrodermatitis chronica atrophicans. Infection 24 1 (1996) 85-87
97. Grosshans E. La maladie de Pick-Herxheimer. Ann. Dermatol. Venereol. 129 (2002) 1063-1066
98. Plorer A., Sepp N., Schmutzhard E., Krabichler S., Trobos S., Schauer G., et al. Effects of adequate versus inadequate treatment of cutaneous manifestations of Lyme borreliosis on the incidence of late complications and late serologic status. J. Invest. Dermatol. 100 2 (1993) 103-109
99. De Koning J., Tazelaar D.J., Hoogkamp-Korstanje J.A., and Elema J.D. Acrodermatitis chronica atrophicans: a light and electron microscopic study. J. Cutan. Pathol. 22 1 (1995) 23-32
100. Marsch W.C., Mayet A., and Wolter M. Cutaneous fibroses induced by Borrelia burgdorferi. Br. J. Dermatol. 128 (1993) 674-678
101. Kindstrand E., Nilsson B.Y., Hovmark A., Pirskanen R., and Asbrink E. Peripheral neuropathy in acrodermatitis chronica atrophicans- a late Borrelia manifestation. Acta Neurol. Scand. 95 (1997) 338-345
102. Kindstrand E., Nilsson B.Y., Hovmark A., Pirskanen R., and Asbrink E. Peripheral neuropathy in acrodermatitis chronica atrophicans- effect of treatment. Acta Neurol. Scand. 106 5 (2002) 253-257
103. Luyasu V., and Bouffioux B. Usefulness of laboratory investigations for the diagnosis of acrodermatitis chronica atrophicans. Acta Clin. Belg. 57 4 (2002) 223-226
104. Buechner S.A., Rufli T., and Erb P. Acrodermatitis chronic atrophicans: a chronic T-cell-mediated immune reaction against Borrelia burgdorferi? Clinical, histologic, and immunohistochemical study of five cases. J. Am. Acad. Dermatol. 28 3 (1993) 399-405
105. Garbe C., Stein H., Dienemann D., and Orfanos C.E. Borrelia burgdorferi-associated cutaneous B cell lymphoma: clinical and immunohistologic characterization of four cases. J. Am. Acad. Dermatol. 24 4 (1991) 584-590
106. Jelic S., and Filipovic-Ljeskovic I. Positive serology for Lyme disease Borrelia in primary cutaneous B-cell lymphoma: a study in 22 patients; is it a fortuitous finding?. Hematol. Oncol. 17 3 (1999) 107-116
107. Cerroni L., Zochling N., Putz B., and Kerl H. Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma. J. Cutan. Pathol. 24 8 (1997) 457-461
108. Goodlad J.R., Davidson M.M., Hollowood K., Ling C., MacKenzie C., Christie I., et al. Primary cutaneous B-cell lymphoma and Borrelia burgdorferi infection in patients from the Highlands of Scotland. Am. J. Surg. Pathol. 9 (2000) 1279-1285
109. Kütting B., Bonsmann G., Metze D., Luger T.A., and Cerroni L. Borrelia burgdorferi-associated primary cutaneous B cell lymphoma:complete clearing of skin lesions after antibiotic pulse therapy or intralesional injection of interferon alfa-2a. J. Am. Acad. Dermatol. 36 (1997) 311-314
110. Hofbauer G.F., Kessler B., Kempf W., Nestle F.O., Burg G., and Dummer R. Multilesional primary cutaneous diffuse large B-cell lymphoma responsive to antibiotic treatment. Dermatology 203 2 (2001) 168-170
111. Munksgaard L., Frisch M., Melbye M., and Hjalgrim H. Incidence patterns of Lyme disease and cutaneous B-cell non-Hodgkin's lymphoma in the United States. Dermatology 201 4 (2000) 353-355
112. Wood G.S., Kmath N.V., Guitart J., Heald P., Kohler S., Smoller B.R., et al. Absence of Borrelia burgdorferi DNA in cutaneous B cell lymphomas from the United States. J. Cutan. Pathol. 28 (2001) 502-507
113. Chunmei L., Inagaski H., Okabe M., and Eimoto T. Primary cutaneous marginal zone B-cell lymphoma. Am. J. Surg. Pathol. 27 8 (2003) 1061-1069
114. de la Fouchardiere A., Vandenesch F., and Berger F. Borrelia-associated primary cutaneous MALT lymphoma in a nonendemic region. Am. J. Surg. Pathol. 27 5 (2003) 702-703
115. Peterson L.S., Nelson A.M., and Su W.P. Classificationof morphea (localized scleroderma). Mayo Clin. Proc. 70 (1995) 1068-1076
116. Aberer E., Neumann R., and Staneck G. Is located scleroderma a Borrelia infection?. Lancet ii (1985) 278
117. Vaillant L., and Goudeau A. Localized scleroderma is not a Borellia burgdorferi infection in France. Dermatology (1992) 184-286
118. Muhlemann M.F., Wright D.J.M., and Black C. Serology of Lyme disease. Lancet ii (1986) 553-554
119. Hansen K., Serup J., and Hoybye S. Antibodies to Borrelia burgdorferi and localized scleroderma. Lancet i (1987) 682
120. Hoesly J.M., Lester E.M., and Winkelmann R.K. Localized scleroderma (morphea) and antibodies to Borrelia burgdorferi. J. Am. Acad. Dermatol. 17 (1987) 455-458
121. Halkier Sorensen L., Kragballe K., and Hansen K. Antibodies to the Borrelia burgdorferi Flagelleum in patients with scleroderma, granuloma annulare and porphyria cutanea tarda. Acta Derm. Venereol. 69 (1989) 116-119
122. Raguin G., Boisnic S., Souteyrand P., Baranton G., Piette J.C., Godeau P., et al. No evidence for a spirochetal origin of localized scleroderma. Br. J. dematol. 127 (1992) 218-220
123. Meis J.F., Koopman R., Van Bergen B., Pool G., and MelchersW. No evidence for relation between Borrelia burgdorferi infection and old lesions of localized scleroderma (morphea). Arch. Dermatol. 129 (1993) 386-387
124. Ranki A., Aavvik E., Peterson P., Schauman K., and Nurmilaakso P. Successfull amplification of DNA specific for Finish Borrelia burgdorferi isolates in erythema chronicum migrans but not in circumscribed scleroderma lesions. J. Invest. Dermatol. 102 (1994) 339-345
125. Fan W., Leonardi G.L., and Penneys N.S. Absence of Borrelia burgdorferi in patients with localized scleroderma (morphea). J. Am. Acad. Dermatol. 33 (1995) 682-684
126. Wienecke R., Schlüpen E.M., Zöling N., Neubert U., Meurer M., and Volkenandt M. No evidence for Borrelia burgdorferispecific DNA in lesions of localized scleroderma. J. Invest. Dermatol. 104 (1995) 23-26
127. Dillon W.I., Saed G.M., and Fivenson D.P. Borrelia burgdorferi DNA is undetectable by polymerasechain reaction in skin lesions of morphea, scleroderma, or lichen sclerosus et atrophicus of patients from North America. J. Am Acad. Dermatol. 33 (1995) 617-620
128. Alonso-Llamazares J., Persing D.H., Anda P., Gibson L.E., Rutledge B.J., and Iglesias L. No evidence for Borrrelia burgdorferi infection in lesions of morphea ans lichen sclerosus et atrophicus in Spain : a prospective study and literature review. Acta. Dermatol. Venereol. 77 (1997) 299-304
129. Weide B., Schittek B., Klyscz T., Schüz, Stark M., Rassner G., et al. Morphea is neither assciated with features of Borrelia burgdorferi infection, nor is this agent detectable in lesional skin by polymerase chain reaction. Br. J. Dermatol. 143 (2000) 780-785
130. Neubert V., Gerstner H., Meurer M., and Krieg T. Spirochetal antibodies in morphea. J. Invest. Dermatol. 86 (1986) 336
131. Aberer E., Stanek G., Erth M., and Neumann R. Evidence for spirocheatl origin of cicumscribed scleroderma (morphea). Acta Derm. Venereol. 67 (1987) 225-231
132. Weber K., Preac-Mursic V., and Reimers C.D. Spirochetes isolated from two patients with morphea. Infection 16 (1988) 25-26
133. Aberer E., and Stanek G. Histological evidence for spirochetal origin of morphea and lichen sclerosus et atrophicans. Am. J. Dermatopathol. 9 (1987) 374-379
134. Scott A.R., Sanchez J.L., and Taboas J.O. Spirocheatl forms in the dermal lesions of morphea and lichen sclerosus and atrophicus. Am. J. Dermatopathol. 12 (1990) 357-362
135. Abele D.C., and Anders K.H. The many faces of borrelisosis II. J. Am. Acad. Dermatol. 3 (1990) 401-410
136. Coulson I.H., Smith N.P., and Holden C.A. Acrodermatitis chronica atrophicans with coexisting morphea. Br. J. Dermatol. 121 (1989) 263-269
137. Aberer E., Klade H., Stanek G., and Gehbart W. Borrelia burgdorferi and different types of morphea. Dermatologica 182 (1991) 145-154
138. Buechner S.A., Winkelmann R.K., Lautenshlager S., Gilli L., and Rufli T. Localized scleroderma associated with Borrelia burgdorferi infection: clinical, histologic, and immunohistochemical observations. J. Am. Acad. Dermatol. 29 (1993) 190-196
139. Buechner S.A., Lautenschlager S., Itin P., Bircher A., and Erb P. Lymphoproliferative responses to Borrelia burgdorferi in patients with Erythema migrans, Acrodermatitis Chronica atrophicans. Lymphadenosis Benigna Cutis, and Morphea Arch. Dermatol. 131 (1995) 673-677
140. Breier F., Klade H., Staneck G., Poitschek C., Kirnbauer R., Dorda W., et al. Lymphoproliferative responses to Borrelia burgdorferi in circumscribed scleroderma. Br. J. Dermatol. 134 (1996) 285-291
141. Schempp C., Bocklage H., Lange R., Kölmel H.W., Orfanos C.E., and Gollnick H. Further evidence for Borrelia burgdorferi infection in morphea and lichen sclerosus et atrophicus confirmed byDNA amplification. J. Invest. Dermatol. 100 (1993) 717-720
142. Fujiwara H., Fujiwara K., Hashimoto K., Mehregan A.H., Schaumburg-lever G., Lange R., et al. Detection of Borrelia burgdorferi DNA (Borrelia garinii or Borrelia Afzelii) in morphea and lichen sclerosus et atrophicus tissues of German and Japanese but not of Us patients. Arch. Dermatol. 133 (1997) 41-44
143. Abele D.C., Bedingfield R.B., Chandler F.W., and Given K.S. Progressive facial hemiatrophy(Parry-romberg syndrome) and borreliosis. J. Am. Acad. Dermatol. 22 (1990) 531-533
144. Breier F.H., Aberer E., Stanek G., Khanakah G., Schlick A., and Tappeiner G. Isolation of Borrelia afzelii from circumscribed scleroderma. Br. J. Dermatol. 140 (1999) 925-930
145. Ozkan S., Atabey N., Fetil E., Erkizan V., and Gunes A.T. Evidence for Borrelia burgdorferi in morphea and lichen sclerosus. Int. J. Dermatol. 39 (2000) 278-283
146. Breier F., Khanakah G., Stanek G., Kunz G., Aberer E., and Schmidr B. Tappeiner G isolation and polymerase chain reaction typing of Borrelia Afzelii from a skin lesion in a seronegative patient with generalized ulcerating bullous lichen sclerosus et atrophicus. Br. J. Dermatol. 144 (2001) 387-392
147. Weide B., Walz T., and Garbe C. Is morphoea caused by Borrelia burgdorferi?A review. Br. J. Dermatol. 142 (2000) 636-644
148. Zoschke D.C., Skemp A.A., and Defosse D.L. Lymphoproliferative responses to Borrelia burgdorferi in Lyme disease. Ann. Intern. Med. 114 (1991) 285-289
149. Sommer A., Gambichler T., Bacharach-Buhles M., von Rothenburg T., Altmeyer P., and Kreuter A. Clinical and serological characteristic of progressive facial hemiatrophy : a case series of 12 patients. J. Am. Acad. Dermatol. 54 (2006) 227-233
150. Salpietro D.C., Merlino M.V., Bruglia S., Guarneri F., and Vaccaro M. Linear scleroderma « en coup de sabre » associated with facial atrophy in a patient seropositive for Borrelia burgdorferi: a true case of molecular mimicry?. Pediatr. Allergy Immunol. 15 6 (2004) 570-572
151. Steere A.C., Duray P.H., Danny J.H., Kauffmann M.D., Gary P., and Wormser M.D. Unilateral blindness caused by infection with the Lyme disease spirochete, Borrelia burgdorferi. Ann. Intern. Med. 103 (1985) 382-384
152. Huppertz H.I., Munchmeier D., and Lieb W. Ocular manifestations in children and adolescents with Lyme arthritis. Br. J. Ophtalmol. 83 (1999) 1149-1152
153. Mikkilä H.O., Seppälä I.J.T., Viljanen M.K., Peltomaa M.P., and Karma A. The expanding clinical spectrum of ocular Lyme borreliosis. Ophtalmology 107 (2000) 581-587
154. Lesser R.L. Ocular Manifestations of Lyme disease. Am. J. Med. 98 suppl4A (1995) 60S-62S
155. Aaberg T. The expanding ophtalmologic spectrum of Lyme disease. Am. J. Ophtalmol. 107 (1989) 77-80
156. Mombaerts I.M., Maudgal P.C., and Knockaert D.C. Bilateral follicular conjunctivitis as a manifestation of Lyme disease. Am. J. Ophthalmol. 112 (1991) 96-97
157. Orlin S.E., and Lauffer J.L. Lyme disease keratitis. Am. J. Ophtalmol. 107 (1989) 678-680
158. Bertuch A.W., Rocco E., and Schwartz E.G. Lyme disease: ocular manifestations. Ann. Ophtalmol. 20 (1988) 376-378
159. Baum J., Barza M., Weinstein P., Groden J., and Asward M. Bilateral keratitis as a manifestation of Lyme disease. Am. J. Ophtalmol. 105 (1988) 75-77
160. Kornmehl E.W., Lesser R.L., Jaros P., Rocco E., and Steere A.C. Bilateral keratitis in Lyme disease. Ophtalmology 96 (1989) 1194-1197
161. Zaidman G.W. Episcleritis and symblepharon associated with Lyme disease. Am. J. Ophtalmol. 109 (1990) 487-488
162. Krist D., and Wenkel H. Posterior scleritis associated with Borrelia burgdorferi infection. Ophtalmology 109 (2002) 143-145
163. Boutros A., Rahn E., and Nauheim R. Iritis and pillitis as a primary presentation of Lyme disease. Ann. Ophtalmol. 22 (1990) 24-25
164. Winward K.E., Smith J.L., Culbertson W.W., and Paris-Hamelin A. Ocular Lyme borreliosis. Am. J. Ophtalmol. 108 (1989) 651-657
165. Breeveld J., Rothova A., and Kuiper H. Intermediate uveitis and Lyme borreliosis. J. Ophtalmol. 76 (1992) 181-182
166. Karma A., Pirttilä T.A., Viljanen M.K., Lähde Y.E., and Raitta C.M. Secondary retinitis pigmentosa and cerebral demyelinisation in Lyme borreliosis. Br. J. Ophthalmol. 77 (1993) 120-122
167. Kadz B., Putteman A., Verougstraete C., and Caspers L. La maladie de Lyme du point de vue de l'ophtalmologue. J. Fr. Ophtalmol. 28 (2005) 218-223
168. Rothova A., Kuiper H., Spanjaard L., Dankert J., and Breebaart A.C. Spiderweb vitritis in Lyme borreliosis. Lancet 337 (1991) 490-491
169. Suttorp-Schulten M.S.A., Kuiper H., Kijlstra A., van Dam A.P., and Rothova A. Long-term effects of ceftriaxone treatment on intraocular Lyme borreliosis. Am. J. Ophtalmol. 116 (1993) 571-575
170. Kuiper H., Hans J., Koelman T.M., and Jager M.J. Vitreous clouding associated with Lyme borreliosis. Am. J. Ophtalmol. 108 (1989) 453-454
171. Hilton E., and Smith C. Sood sunil ocular Lyme borreliosis diagnosed by polymerase chain reaction on vitreous fluid. Ann. Intern. Med. 125 (1996) 424-425
172. Kauffmann D.J., and Wormser G.P. Ocular Lyme disease; a case report and review of the literature Journal. Ophtalmol. 74 (1990) 325-327
173. Smith J.L., Winward K.E., Nicholson D.F., and Albert D.W. Retinal vasculitis. J. Clin. Neuroophtalmol. 11 (1991) 7-15
174. Lang G.E., Schönherr U., and Naumann G.O.H. Retinal vasculitis with proliferative retinopathy in a patient with evidence of Borrelia burgdorferi infection. Am. J. Ophthalmol. 111 (1991) 243-244
175. Lightman D.A., and Brod R. Branch retinal artery occlusion associated with Lyme disease. Arch. Ophtalmol. (Paris) 19 (1991) 1198-1199
176. Niutta A., Barcaroli I., and Palombi E. Monolaterla chorioretinitis with multiple foci in one case of Lyme disease. Ann. Ophtalmol 25 (1993) 257-261
177. Lardenoye C.W., Van der Lelij A., de Loos W.S., Treffers W.F., and Rothova A. Peripheral multifocal chorioretinitis. Ophtalmology 104 (1997) 1820-1826
178. Macarez R., Bazin S., Lagauche D., Soullié B., Giordano P., May F., et al. Révélation d'une neuropathie optique héréditaire de Leber dans un contexte de borréliose. J. Fr. Ophtalmol. 28 (2005) 1095-1100
179. Lesser R.L., Kormehl E.W., Pachner A.R., Kattah J., Hedges T.R., Newman N., et al. Neuro-ophtalmologic manifestaions of Lyme disease. Ophtalmology 97 (1990) 699-706
180. Rothermel H., Hedge T.R., and Steere A.C. Optic neuropathy in children with Lyme disease. Pediatrics 108 (2001) 477-481
181. Schlechter S.L. Lyme disease associated with optic neuropathy. Am. J. Med. 81 (1985) 143-145
182. Arnold R.W., and Schriever G. Lyme amaurosis in a child. J. Pediatr. Ophtalmol. Strabismus 30 (1993) 268-270
183. Seidenberg K.B., and Leib M.L. Orbital myosistis with Lyme disease. Am. J. opthalmol. 103 (1990) 13-16
184. Fatterpekar G.M., Gottesman R.I., Sacher M., and Som P.M. Orbital Lyme disease. MR Imaging before and after treatment: case report. AJNR Am. J. Neuroradiol. 23 (2002) 657-659
185. Carvounis P.E., Mehta A.P., and Geist G.E. Orbital myositis associated with Borrrelia burgdorferi infection. Ophtalmology 111 (2004) 1023-1028
186. Strominger M.B., Slamovits T.L., Hertskotiz S., and Lipton R.B. Transient worsening optic neuropathy as a sequela of the Jarisch-Herxheimer reaction in the treatment of Lyme disease. J. Neuro-ophtalmol 14 (1994) 77-80
187. Jacobson D.M. Lyme disease and optic neuritis: long-term follow-up of seropositive patients. Neurology 60 (2003) 881-882